GeneCapture Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $500K

  • Investors
  • 11

GeneCapture General Information

Description

Developer of a medical diagnostic device designed to detect and identify pathogens and to bring infection detection to the point of care. The company's device screens germs in blood, urine and wounds against a wide array of genetic signatures and reports the results within an hour, enabling medical professionals to detect bacterial and viral infections in a portable instrument for use in clinics, field applications, airports and at borders.

Contact Information

Formerly Known As
SLP Diagnostics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 601 Genome Way
  • Huntsville, AL 35806
  • United States
+1 (256)
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 601 Genome Way
  • Huntsville, AL 35806
  • United States
+1 (256)

GeneCapture Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GeneCapture Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
21. Later Stage VC 06-Dec-2024 $500K Completed Generating Revenue
20. Grant 22-Mar-2023 Completed Generating Revenue
19. Grant 06-Jan-2023 Completed Generating Revenue
18. Grant 24-Aug-2022 Completed Generating Revenue
17. Later Stage VC (Series B) 01-Jan-2022 Completed Generating Revenue
16. Grant 03-Sep-2021 Completed Generating Revenue
15. Later Stage VC (Series AAA) 01-Sep-2021 Completed Generating Revenue
14. Grant 10-Aug-2021 Completed Generating Revenue
13. Grant 14-Jan-2021 $1000K $1.76M Completed Generating Revenue
12. Grant 30-Sep-2020 $250K $1.76M Completed Generating Revenue
To view GeneCapture’s complete valuation and funding history, request access »

GeneCapture Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series AAA
Series AA 589,735 $0.000100 $1 $1 1x $1 7.76%
Series A 791,588 $0.000100 $0.73 $0.73 1x $0.73 10.42%
To view GeneCapture’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

GeneCapture Patents

GeneCapture Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200324284-A1 Integrated cartridge for sample homogenization and nucleic acid fragmentation Active 15-Apr-2019
US-11918996-B2 Integrated cartridge for sample homogenization and nucleic acid fragmentation Active 15-Apr-2019
US-20240246072-A1 Integrated cartridge for sample homogenization and nucleic acid fragmentation Pending 15-Apr-2019
EP-3911783-A1 Methods and systems for determining target sensitivity to a therapeutic formula Pending 17-Jan-2019
US-20220111378-A1 Methods and systems for determining target sensitivity to a therapeutic formula Pending 17-Jan-2019 B01L3/502
To view GeneCapture’s complete patent history, request access »

GeneCapture Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GeneCapture Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Medical Technology Enterprise Consortium Government
Alabama Launchpad Not-For-Profit Venture Capital
Coplanar Capital Venture Capital Minority
First Avenue Ventures Accelerator/Incubator Minority
HIS Kingdom Resources Fund Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

GeneCapture FAQs

  • When was GeneCapture founded?

    GeneCapture was founded in 2009.

  • Where is GeneCapture headquartered?

    GeneCapture is headquartered in Huntsville, AL.

  • What is the size of GeneCapture?

    GeneCapture has 25 total employees.

  • What industry is GeneCapture in?

    GeneCapture’s primary industry is Biotechnology.

  • Is GeneCapture a private or public company?

    GeneCapture is a Private company.

  • What is GeneCapture’s current revenue?

    The current revenue for GeneCapture is .

  • How much funding has GeneCapture raised over time?

    GeneCapture has raised $7.31M.

  • Who are GeneCapture’s investors?

    Medical Technology Enterprise Consortium, Alabama Launchpad, Coplanar Capital, First Avenue Ventures, and HIS Kingdom Resources Fund are 5 of 11 investors who have invested in GeneCapture.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »